Open Label Study to Assess Efficacy and Safety of the Fully Human Anti-TNF-Alpha Monoclonal Antibody Adalimumab
Clinical trial NCT00650390 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT00650390
- Sponsor
- Abbott
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.